uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

NCT05874921 · clinicaltrials.gov ↗

RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Urothelial Carcinoma
Urothelial Carcinoma Recurrent
Urothelial Carcinoma Ureter
Urothelial Carcinoma Ureter Recurrent
Urothelial Cancer of Renal Pelvis
Urothelial Carcinoma of the Renal Pelvis and Ureter
Carcinoma, Transitional Cell
Transitional Cell Carcinoma of Renal Pelvis

Interventions

DRUG: Jelmyto (mitomycin) for pyelocalyceal solution

Sponsor

UroGen Pharma Ltd.